Ivan Karandashov
Overview
Explore the profile of Ivan Karandashov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tikhonov A, Kachanov A, Yudaeva A, Danilik O, Ponomareva N, Karandashov I, et al.
Pharmaceutics
. 2024 Oct;
16(10).
PMID: 39458635
Biomimetic nanoparticles (BMNPs) are innovative nanovehicles that replicate the properties of naturally occurring extracellular vesicles, facilitating highly efficient drug delivery across biological barriers to target organs and tissues while ensuring...
2.
Brezgin S, Danilik O, Yudaeva A, Kachanov A, Kostyusheva A, Karandashov I, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408730
Extracellular vesicles (EVs) are natural carriers of biomolecules that play a crucial role in cell-to-cell communication and tissue homeostasis under normal and pathological conditions, including inflammatory diseases and cancer. Since...
3.
Brezgin S, Frolova A, Bayurova E, Slatinskaya O, Ponomareva N, Parshina E, et al.
Anal Chem
. 2024 Oct;
96(43):17432-17443.
PMID: 39402710
Extracellular vesicles (EVs), biomimetics, and other biological nanoparticles (BNs) produced from human cells are gaining increasing attention in the fields of molecular diagnostics and nanomedicine for the delivery of therapeutic...
4.
Ponomareva N, Brezgin S, Karandashov I, Kostyusheva A, Demina P, Slatinskaya O, et al.
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794330
Biological nanoparticles (NPs), such as extracellular vesicles (EVs), exosome-mimetic nanovesicles (EMNVs) and nanoghosts (NGs), are perspective non-viral delivery vehicles for all types of therapeutic cargo. Biological NPs are renowned for...
5.
Karandashov I, Kachanov A, Dukich M, Ponomareva N, Brezgin S, Lukashev A, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675942
The epitranscriptomic modification mA is a prevalent RNA modification that plays a crucial role in the regulation of various aspects of RNA metabolism. It has been found to be involved...
6.
Kachanov A, Kostyusheva A, Brezgin S, Karandashov I, Ponomareva N, Tikhonov A, et al.
Med Res Rev
. 2024 Mar;
44(5):2112-2193.
PMID: 38549260
Over the past decade, in vivo gene replacement therapy has significantly advanced, resulting in market approval of numerous therapeutics predominantly relying on adeno-associated viral vectors (AAV). While viral vectors have...